RW Baird Downgrades HCP On Valuation
Analysts at RW Baird downgrade HCP Inc (NYSE: HCP) from "neutral" to "underperform." The target price for HCP is set to $30.
According to RW Baird, the downgrade in rating is based on valuation. Analysts at RW Baird believes that the valuation of HCP’s stock is not consistent with near term fundamentals,
HCP’s shares closed at $33.80 yesterday. More Analyst Ratings here
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
We're Loving
